Drugs News and Research

RSS

Research identifies specific brain cells that trigger sugar consumption and cravings

New research has identified the specific brain cells that control how much sugar you eat and how much you crave sweet tasting food.

12 Jul 2020

New guidance published for research on HIV, co-infections in pregnancy

Pregnant women are among those most in need of safe and effective preventives and treatments for HIV and co-infections. Yet because they are commonly excluded from research, they are among the least likely to have robust, timely evidence to inform decisions around the use of medications.

12 Jul 2020

New mutation in common subtype of influenza virus helps evade immune response

Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

12 Jul 2020

Fat cell hormone enhances therapeutic potential of MSC therapy

Mesenchymal stem cells (MSCs) have the potential to differentiate into a range of different cell types, including bone, fat, and muscle cells.

12 Jul 2020

Newly discovered chemical compound shows potential to become treatment for brain disorders

Researchers at IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology) discovered a novel chemical compound, which has the potential to became a new drug for the treatment of core symptoms of brain disorders like Down syndrome and autism.

11 Jul 2020

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

Lopinavir is a drug against HIV, hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs were regarded as potential agents in the fight against the coronavirus SARS-CoV-2.

11 Jul 2020

UQ researchers reveal three-dimensional structure of important enzyme

Advanced herbicides and treatments for infection may result from the unravelling of a 50-year-old mystery by University of Queensland researchers.

11 Jul 2020

Newly identified gene variants in Black Americans could lead to precision prostate cancer therapies

Black men in the United States are known to suffer disproportionately from prostate cancer, but few studies have investigated whether genetic differences in prostate tumors could have anything to do with these health disparities.

11 Jul 2020

Researchers set up Gate2Brain to exploit a novel drug-transporting technology

Researchers from IRB Barcelona, the University of Barcelona (UB) and the Sant Joan de Déu Research Institute - Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel technology developed at IRB Barcelona to transport drugs into the brain.

10 Jul 2020

Scientists identify a new role for covalent linker in transmembrane ion channels

In the molecular-level world of ion channels - passageways through membranes that carry signals in a cell's environment and allow it to respond - researchers have debated about the role of a small piece of the channel called a linker, says computational biophysicist Jianhan Chen at the University of Massachusetts Amherst.

10 Jul 2020

New clinical trial to assess safety and efficacy of convalescent plasma to prevent COVID-19

There is only one approved, specific treatment for COVID-19, the illness caused by the novel coronavirus SARS-CoV-2, albeit with modest efficacy.

10 Jul 2020

Study sheds new light on neurobiological processes that control drug-related adaptations

The lab of Jeremy Day, Ph.D., at the University of Alabama at Birmingham, has used single-nucleus RNA sequencing approaches to compare transcriptional responses to acute cocaine in 16 unique cell populations from a portion of the brain called the nucleus accumbens, or NAc.

10 Jul 2020

Senators Cassidy and Carper urge CMS to update restrictive coverage policies on obesity drugs and IBT

U.S. Senators Bill Cassidy (R-La.) and Thomas Carper (D-Del.) are calling on the Centers for Medicare & Medicaid Services to lift regulations that deny insurance coverage for obesity drugs and that limit coverage of Intensive Behavioral Therapy amid the COVID-19 pandemic.

10 Jul 2020

Pigs and chickens not susceptible to SARS-CoV-2

A team of researchers in Germany aimed to investigate the susceptibility of potential animal hosts and the risk of zoonosis spill-over infections, which are illnesses transmitted to humans from animals. On the other hand, reverse zoonosis pertains to infections in humans that jump to animals.

9 Jul 2020

Remdesivir potently inhibits SARS-CoV-2 in human lung cell cultures

The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.

9 Jul 2020

Promising new approach uses natural killer cells to treat glioblastomas

Glioblastomas are the most common malignant brain tumors in adults. Treatment options are extremely limited and usually not effective, leading to death for most patients within 12-18 months of diagnosis.

9 Jul 2020

SARS-CoV-2 a dagger to the aging heart

Researchers in Europe have shown that genes involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are expressed to a higher degree in older heart muscle cells (cardiomyocytes) than they are in younger cardiomyocytes.

9 Jul 2020

Use of whole blood transcriptomes may improve COVID-19 diagnosis and treatment

In a new paper published on the preprint server medRxiv*, a multinational group of researchers provide the first evidence for the use of whole blood transcriptomics to distinguish coronavirus disease (COVID-19) from other infections, and also to monitor and potentially predict disease outcomes.

9 Jul 2020

UNM study sheds new light on transition of fear to anxiety

A deadly coronavirus pandemic, economic instability and civil unrest menace the mental well-being of millions.

9 Jul 2020

Insilico Medicine, Arctoris announce technology partnership to discover new COVID-19 drugs

Insilico Medicine, a biotechnology company developing an end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, today announced a technology partnership with Arctoris, the world's first fully automated drug discovery platform, offering remotely accessible, pre-optimized and fully validated R&D processes for its partners and clients globally.

9 Jul 2020

Drugs News and Research

Research identifies specific brain cells that trigger sugar consumption and cravings

New guidance published for research on HIV, co-infections in pregnancy

New mutation in common subtype of influenza virus helps evade immune response

Fat cell hormone enhances therapeutic potential of MSC therapy

Newly discovered chemical compound shows potential to become treatment for brain disorders

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

UQ researchers reveal three-dimensional structure of important enzyme

Newly identified gene variants in Black Americans could lead to precision prostate cancer therapies

Researchers set up Gate2Brain to exploit a novel drug-transporting technology

Scientists identify a new role for covalent linker in transmembrane ion channels

New clinical trial to assess safety and efficacy of convalescent plasma to prevent COVID-19

Study sheds new light on neurobiological processes that control drug-related adaptations

Senators Cassidy and Carper urge CMS to update restrictive coverage policies on obesity drugs and IBT

Pigs and chickens not susceptible to SARS-CoV-2

Remdesivir potently inhibits SARS-CoV-2 in human lung cell cultures

Promising new approach uses natural killer cells to treat glioblastomas

SARS-CoV-2 a dagger to the aging heart

Use of whole blood transcriptomes may improve COVID-19 diagnosis and treatment

UNM study sheds new light on transition of fear to anxiety

Insilico Medicine, Arctoris announce technology partnership to discover new COVID-19 drugs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News